36 related articles for article (PubMed ID: 6061066)
1. [Clinical considerations on the therapeutic effect of a new non-anticholinergic antisecretory preparation: Milid (xylamide, CR 242)].
Castelli CA; Locatelli L; Salvioni GF
Minerva Med; 1967 Oct; 58(86):3704-8. PubMed ID: 6061065
[No Abstract] [Full Text] [Related]
2. [Signs of tolerability in man, clinical pharmacology and activity of a new non-anticholinergic product active in gastroduodenitis and gastroduodenal ulcer (Milid)].
Casone A; Borellini D; Jezzi B
Minerva Med; 1967 Oct; 58(86):3699-704. PubMed ID: 6061064
[No Abstract] [Full Text] [Related]
3. [Clinical evaluation, in gastritis and gastroduodenal ulcers of a new non-anticholinergic compound with protective and antisecretory activity].
Fantino M; Roccia L
Minerva Med; 1967 Oct; 58(86):3677-85. PubMed ID: 6061061
[No Abstract] [Full Text] [Related]
4. [Antisecretory therapeutic activity of Milid (xylamide, CR 242) in the treatment of gastroduodenal ulcer].
Giordano G; Comi L
Minerva Med; 1967 Oct; 58(86):3688-91. PubMed ID: 6061062
[No Abstract] [Full Text] [Related]
5. [Therapy of some conditions of chronic gastroduodenitis and of gastroduodenal ulcer with a preparation, for intravenous or intramuscular injection or oral administration, derived from a carboxyl halicyclic acid].
Abbona C; Gatto PL; Bezante GC
Minerva Med; 1967 Oct; 58(86):3691-9. PubMed ID: 6061063
[No Abstract] [Full Text] [Related]
6. [Pharmacological and clinical studies of a non-anticholinergic antisecretory product: Milid (xylamide, CR 242)].
Mainoli S; Milvio C; Borellini D
Minerva Med; 1967 Oct; 58(86):3708-12. PubMed ID: 6061066
[No Abstract] [Full Text] [Related]
7. The use of antacids in the treatment of peptic ulcer.
Grossman MI
Scand J Gastroenterol Suppl; 1980; 58():37-40. PubMed ID: 6988940
[No Abstract] [Full Text] [Related]
8. [Medical treatment of peptic ulcer].
Meeroff JC; Meeroff M
Rev Esp Enferm Apar Dig; 1977 Feb; 49(2):251-84. PubMed ID: 319516
[No Abstract] [Full Text] [Related]
9. [Antacids and antipeptic agents].
Belousov AS; Mamedova LD; Zel'din VE; Rakitskaia LG; Loranskaia ID
Klin Med (Mosk); 1989 Sep; 67(9):123-9. PubMed ID: 2511377
[No Abstract] [Full Text] [Related]
10. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
Scarpignato C; Pelosini I
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
[TBL] [Abstract][Full Text] [Related]
11. Antacid and anticholinergic drug therapy of peptic ulcer.
Piper DW
Gastroenterology; 1967 Jun; 52(6):1009-18. PubMed ID: 5338230
[No Abstract] [Full Text] [Related]
12. [Management of the peptic ulcer patient in the Helicobacter pylori age].
Marshall BJ
Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():36-40. PubMed ID: 7914434
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
